Score Breakdown
Below average.
IonQ is a speculative quantum computing platform company trading at 81x TTM revenue with deeply negative unit economics, massive dilution (69% annually), SBC exceeding revenue by 2x, and $1.26B in acquisition goodwill at risk of impairment. While the $370M RPO and $3.3B cash position provide near-term runway, the path to profitability is extremely long (likely 2030+), and per-share value is being systematically destroyed through continuous equity issuance. The Wolfpack short report raises legitimate concerns about revenue quality (66% unbilled receivables) and government contract dependency. The SkyWater acquisition transforms this from a quantum pure-play into a semiconductor foundry operator, diluting the narrative. With Quantinuum preparing an IPO and big tech (Google, IBM, Microsoft) investing heavily in competing approaches, IonQ's technological moat is narrower than management claims. At ~$10.5B market cap for a company burning $600M+/year with $130M in revenue, the valuation requires flawless execution on a decade-long roadmap in an industry where commercial quantum advantage remains unproven.
Negative cash flow. Can't value it.
Some yellow flags.
Shares melting fast.
Execs cashing out.
Plenty of cash.
Heavy bearish bets.
Below average.
🐻 Why Bears Hate It
The bear case centers on a projected '$54.6 million black hole' in 2025/2026 bookings caused by the expiration of 'backdoor earmark' government contracts (Wolfpack Research). Skeptics argue IonQ is no longer a 'quantum pure-play' following its $1.8 billion acquisition of semiconductor foundry SkyWater Technology, which bears lower margins and high cyclicality (Stocktwits, 24/7 Wall St). Furthermore, adjusted EBITDA losses are projected to widen significantly to $310M–$330M in 2026 (TradingView).
🔍 What's In The SEC Filings
IonQ is operating as a capital-recycling vehicle, utilizing massive equity raises and stock-based compensation to fund growth and acquisitions that are primarily comprised of non-productive goodwill.
Preponderance of Unbilled Receivables
“Unbilled accounts receivable 24,334 [thousand] ... Billed accounts receivable 12,578 [thousand]”
66% of total accounts receivable are unbilled, indicating that revenue is being recognized well ahead of cash collection, likely through subjective 'cost-to-cost' POC modeling which is highly susceptible to management bias.
Aggressive and Continuous Equity Dilution
“The offering closed on October 14, 2025, for aggregate proceeds of approximately $1,980.0 million, net of certain issuance costs.”
Between March and October 2025, the company executed three massive equity raises totaling over $3.3 billion, significantly diluting existing shareholders to fund a speculative technology roadmap.
Stock-Based Compensation Exceeds Total Revenue
“Total stock-based compensation $ 74,623 [thousand] ... Total revenue $ 39,866 [thousand]”
The company is paying nearly double its total quarterly revenue in stock-based compensation, creating an unsustainable circular dependency on a high share price to retain talent and fund operations.
Massive Goodwill Concentration in M&A
“The goodwill of $1,261.5 million is primarily attributable to specialized assembled workforce and expected future synergies”
The Oxford Ionics acquisition was valued at $1.59B, with 79% of the purchase price allocated to goodwill. This creates a high risk of future multi-billion dollar impairments if integration or technology milestones fail.
Traditional earnings multiples are useless; intrinsic value is highly sensitive to the Level 3 warrant assumptions and the successful integration of $1.8B+ in recent goodwill-heavy acquisitions. Significant haircut required for dilution risk.
Insider selling through 10b5-1 modifications by the CRO and directors occurred shortly before or during massive dilution cycles, suggesting a lack of alignment with long-term retail holders.